Ways to Support Those with Pediatric Growth Hormone Deficiency
source: pixabay.com

Ways to Support Those with Pediatric Growth Hormone Deficiency

Growth hormone deficiency (GHD) influences patients both physically and mentally. The condition means patients' bodies don't produce enough growth hormone. As a result, they don't develop the same way as…

Continue Reading Ways to Support Those with Pediatric Growth Hormone Deficiency

Study Illuminates Treatment Options for Different Pediatric Adrenocortical Carcinoma Stages

A study published in the Journal of Clinical Oncology has detailed the benefits of different forms of treatment for pediatric patients with adrenocortical carcinoma. These researchers particularly looked at what treatments…

Continue Reading Study Illuminates Treatment Options for Different Pediatric Adrenocortical Carcinoma Stages

Phase 3 Trial for Pediatric Growth Hormone Deficiency in China Completed Enrollment On Time Despite COVID-19 Setback

VISEN Pharmaceuticals has recently announced that enrollment has been completed for their Phase 3 clinical trial examining the safety and efficacy of TransCon hGH compared to daily rhGH in patients…

Continue Reading Phase 3 Trial for Pediatric Growth Hormone Deficiency in China Completed Enrollment On Time Despite COVID-19 Setback
Case Study: Guillain-Barre Syndrome in a Patient with Severe COVID-19
source: pixabay.com

Case Study: Guillain-Barre Syndrome in a Patient with Severe COVID-19

In a case study published on dovepress.com, a 17 year old girl diagnosed with COVID-19 developed Guillain-Barre syndrome, a neurological disease causing muscle weakness, as her symptoms progressed. While COVID-19…

Continue Reading Case Study: Guillain-Barre Syndrome in a Patient with Severe COVID-19
LX1001 for APOE4-Associated Alzheimer’s Granted Fast Track Designation
Thor_Deichmann / Pixabay

LX1001 for APOE4-Associated Alzheimer’s Granted Fast Track Designation

  In a recent press release, biotechnology and gene therapy company LEXEO Therapeutics ("LEXEO") shared that its gene therapy LX1001 received Fast Track designation from the FDA. Overall, LX1001 is…

Continue Reading LX1001 for APOE4-Associated Alzheimer’s Granted Fast Track Designation
Long COVID/Myalgic Encephalomyelitis Continues to Receive Criticism from Psychiatrists
source: pixabay.com

Long COVID/Myalgic Encephalomyelitis Continues to Receive Criticism from Psychiatrists

According to a story from insidesources.com, many in the chronic fatigue syndrome/myalgic encephalomyelitis community has been very grateful for the news that the National Institutes of Health (NIH) has committed…

Continue Reading Long COVID/Myalgic Encephalomyelitis Continues to Receive Criticism from Psychiatrists